ReviewDiscover mental health2025
Prevalence and predictors of depression in tuberculosis patients in india: a systematic review and meta-analysis.
Review in Discover mental health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Depressive symptoms and their associations with tuberculosis-related knowledge, attitudes, and practices among patients with multidrug-resistant tuberculosis.Frontiers in public health · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionTB and common mental disorders pose significant global health challenges that considerably impact human health. The combination of depression with TB can lead to a poor quality of life, low medication adherence, progression to drug-resistant tuberculosis, and ultimately, mortality.
objectivesThis study aimed to estimate the pooled prevalence of depression in TB patients and identify the predictors of depression in this population in India.
methodsThe preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed for reporting this systematic review and meta-analysis. Data were extracted from October to December 2024 using the PUBMED, Scopus, EMBASE, and DOAJ databases. A total of 25 articles were selected, and the included articles underwent quality assessment using the Joanna Briggs Institute Critical Appraisal checklist. The pooled prevalence of depression in TB patients was estimated at a 95% confidence interval using a random effects model, assuming potential heterogeneity. STATA 18 (Stata Corp LLC, College Station, TX, USA) was used for analysis.
resultsThe total sample across 25 studies included 12,033 (Mean(SD) = 481(1377), Median = 169, IQR = 106-302). The pooled prevalence of depression in TB patients in India was estimated at 37% (95% CI: 26- 49%). A subgroup analysis based on the types of TB cases indicated that the prevalence of depression in different kinds of TB cases did not vary substantially, with 39% (95% CI: 26- 54%) in both Drug-Resistant (DR) and Drug-Sensitive (DS) Tuberculosis (TB) cases, followed by DR-TB cases [36% (95% CI: 09-68%)] and DS-TB cases [32% (95% CI: 14- 53%)]. Of the nine assessment tools used to assess depression, the pooled prevalence utilising the Patient Health Questionnaire (PHQ)-9 tool was highest [43% (95% CI: 31-56%)]. There was considerable heterogeneity (I
conclusionThe study found that over one-third of TB patients experienced depression. The coexistence of depression and TB constitutes a significant public health issue that needs addressing at both the community and health facility levels.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.